Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kayoko Shoda"'
Autor:
Kohei Shitara, Satoshi Ueha, Shigeyuki Shichino, Hiroyasu Aoki, Haru Ogiwara, Tetsuya Nakatsura, Toshihiro Suzuki, Manami Shimomura, Toshiaki Yoshikawa, Kayoko Shoda, Shigehisa Kitano, Makiko Yamashita, Takayuki Nakayama, Akihiro Sato, Sakiko Kuroda, Masashi Wakabayashi, Shogo Nomura, Shoji Yokochi, Satoru Ito, Kouji Matsushima, Toshihiko Doi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Background Transient CD4+ T cell depletion led to the proliferation of tumor-specific CD8+ T cells in the draining lymph node and increased infiltration of PD-1+CD8+ T cells into the tumor, which resulted in strong anti-tumor effects in tumo
Externí odkaz:
https://doaj.org/article/f3fa5960399a4030b38ca80859495c2b
Autor:
Nobuhiro Tsuchiya, Ako Hosono, Toshiaki Yoshikawa, Kayoko Shoda, Kazuto Nosaka, Manami Shimomura, Junichi Hara, Chika Nitani, Atsushi Manabe, Hiroki Yoshihara, Yosuke Hosoya, Hide Kaneda, Yoshiaki Kinoshita, Kenichi Kohashi, Kenichi Yoshimura, Norihiro Fujinami, Keigo Saito, Shoichi Mizuno, Tetsuya Nakatsura
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
The carcinoembryonic antigen glypican-3 (GPC3) is a good target of anticancer immunotherapy against pediatric solid tumors expressing GPC3. In this non-randomized, open-label, phase I clinical trial, we analyzed the safety and efficacy of GPC3-peptid
Externí odkaz:
https://doaj.org/article/5f76819309494872a07ab5ff75f4dada
Autor:
Junichi Hara, Toshiaki Yoshikawa, Hide Kaneda, Yoshiaki Kinoshita, Atsushi Manabe, Masashi Wakabayashi, Manami Shimomura, Yasunari Nakamoto, Shoichi Mizuno, Miki Fukutani, Kenichi Kohashi, Yu Akazawa, Chika Nitani, Tetsuya Nakatsura, Kayoko Shoda, Ako Hosono, Akihiro Sato
Publikováno v:
Cancer Science
Pediatric refractory solid tumors are aggressive malignant diseases, resulting in an extremely poor prognosis. KOC1, FOXM1, and KIF20A are cancer antigens that could be ideal targets for anticancer immunotherapy against pediatric refractory solid tum
Autor:
Kayoko Shoda, Hideaki Bando, Takashi Kojima, Tetsuro Sasada, Itaru Endo, Satoshi Wada, Kenichi Kohashi, Kazuto Nosaka, Toshiaki Yoshikawa, Yasuhiro Shimizu, Yuki Fujimoto, Tetsuya Nakatsura, Shoichi Mizuno
Publikováno v:
Cancer Science
Heat shock protein 105 (HSP105) is overexpressed in many cancers, including colorectal cancer (CRC) and esophageal cancer (EC). We carried out a phase I clinical trial of HLA‐A24‐ and HLA‐A2‐restricted HSP105 peptide vaccines in patients with
Autor:
Satoru Ito, Toshihiro Suzuki, Makiko Yamashita, Takayuki Nakayama, Sakiko Kuroda, Hiroyasu Aoki, Manami Shimomura, Shoji Yokochi, Toshiaki Yoshikawa, Shogo Nomura, Satoshi Ueha, Kohei Shitara, Kouji Matsushima, Haru Ogiwara, Tetsuya Nakatsura, Shigeyuki Shichino, Akihiro Sato, Toshihiko Doi, Shigehisa Kitano, Kayoko Shoda, Masashi Wakabayashi
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Background Transient CD4+ T cell depletion led to the proliferation of tumor-specific CD8+ T cells in the draining lymph node and increased infiltration of PD-1+CD8+ T cells into the tumor, which resulted in strong anti-tumor effects in tumor-bearing
Autor:
Toshiaki Yoshikawa, Atsushi Manabe, Nobuhiro Tsuchiya, Hide Kaneda, Norihiro Fujinami, Shoichi Mizuno, Ako Hosono, Junichi Hara, Kazuto Nosaka, Keigo Saito, Kenichi Yoshimura, Kenichi Kohashi, Manami Shimomura, Yosuke Hosoya, Yoshiaki Kinoshita, Chika Nitani, Kayoko Shoda, Tetsuya Nakatsura, Hiroki Yoshihara
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Oncoimmunology
Oncoimmunology
The carcinoembryonic antigen glypican-3 (GPC3) is a good target of anticancer immunotherapy against pediatric solid tumors expressing GPC3. In this non-randomized, open-label, phase I clinical trial, we analyzed the safety and efficacy of GPC3-peptid
Autor:
Atsushi Manabe, Hide Kaneda, Junichi Hara, Kenichi Kohashi, Yu Akazawa, Toshiaki Yoshikawa, Yoshiaki Kinoshita, Shoichi Mizuno, Manami Shimomura, Yasunari Nakamoto, Ako Hosono, Tetsuya Nakatsura, Kayoko Shoda, Yoko Shioda
Publikováno v:
Cancer Immunology Research. 7:A001-A001
Recently, the aggressive intervention of multidisciplinary therapy has resulted in improving the life prognosis of pediatric solid tumors. However, in the pediatric patients with metastatic or refractory solid tumors, the prognosis remains poor. Addi
Autor:
Yuki Fujimoto, Satoshi Wada, Shoichi Mizuno, Itaru Endo, Tetsuro Sasada, Toshiaki Yoshikawa, Yasuhiro Shimizu, Kojima Takashi, Kayoko Shoda, Kenichi Kohashi, Kazuto Nosaka, Hideaki Bando, Tetsuya Nakatsura
Publikováno v:
Cancer Immunology Research. 7:A017-A017
Purpose: Heat shock protein 105 (HSP105) is overexpressed in a variety of human cancers, including colorectal cancer (CRC) and esophageal cancer (EC). We identified HLA-A24 or A2-restricted HSP105 peptides that can induce HSP105 peptide-specific cyto